12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

BMN-111: Phase I data

A double-blind, placebo-controlled, U.S. Phase I trial in 48 healthy adult males showed that single and multiple doses of subcutaneous...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >